The British journal of dermatology 2019-11
Utilization patterns and performance of commercial myositis autoantibody panels in routine clinical practice.
Related Questions
New comment by at Emory University ( June 12, 2022)
@Suzanne Gilman: I'm laughing since I did the same thing throughout fellowship. Our division director (Dr. @Peter A. Merkel) happened to find them when traveling through China...
New answer by at Emory University (June 21, 2022)
The short answer is "not great, but it depends" since the more nuanced answer is contingent on:
the constellation of myositis-specific antibodies (MSA) included on th...
New comment by at Rubicon MD ( May 28, 2023)
Dr. @Gandiga, thank you for the detailed explanation.